On the inhibition of deoxycytidylate hydroxymethylase by 5-fluoro-2′-deoxycytidine 5′-monophosphate
-
Add time:07/12/2019 Source:sciencedirect.com
Studies were performed to determine whether 5-fluoro-2′-deoxycytidine 5′-monophosphate (FdCMP) is an inhibitor of deoxycytidylate hydroxymethylase and whether it could form an isolable covalent complex with the enzyme and the cofactor, 5,10-methylenetetrahydrofolate. The results showed that although FdCMP is a competitive inhibitor of dCMP hydroxymethylase, it does not cause time-dependent inhibition of the enzyme in the presence of cofactor. Further, although uv difference spectral evidence was found for a FdCMP-cofactor-enzyme complex, the complex was not sufficiently stable to isolate on nitrocellulose filters. We conclude that FdCMP is not a mechanism-based inhibitor of dCMP hydroxymethylase.
We also recommend Trading Suppliers and Manufacturers of 5-fluoro-2'-deoxycytidine 5'-monophosphate (cas 847-22-3). Pls Click Website Link as below: cas 847-22-3 suppliers
Prev:Synthesis and structure–activity relationship studies of 3-biaryl-8-oxabicyclo[3.2.1]octane-2-carboxylic acid methyl esters
Next:5-Fluoro-2′-deoxycytidine 5′-monophosphate is a mechanism-based inhibitor of thymidylate synthase) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Evaluation of 5-[18F]fluoro-2ʹ-deoxycytidine as a tumor imaging agent: A comparison of [18F]FdUrd, [18F]FLT and [18F]FDG07/15/2019
- Analysis of 5-fluoro-2′-deoxycytidine and 5-trifluoromethyl-2′-deoxycytidine and their related antimetabolites by high-performance liquid chromatography07/14/2019
- 5-Fluoro-2′-deoxycytidine 5′-monophosphate is a mechanism-based inhibitor of thymidylate synthase07/13/2019


